INFANTS WITH VERY HIGH RISK KMT2A B-ALL

Clinical trials for INFANTS WITH VERY HIGH RISK KMT2A B-ALL explained in plain language.

Never miss a new study

Get alerted when new INFANTS WITH VERY HIGH RISK KMT2A B-ALL trials appear

Sign up with your email to follow new studies for INFANTS WITH VERY HIGH RISK KMT2A B-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with Ultra-Rare leukemia: re-engineered immune cell trial opens

Disease control Recruiting now

This study is testing a personalized cell therapy called CART19 for children and young adults with specific, very high-risk types of B-cell acute lymphoblastic leukemia (B-ALL) that are difficult to treat with standard methods. It aims to see if using the patient's own modified i…

Matched conditions: INFANTS WITH VERY HIGH RISK KMT2A B-ALL

Phase: PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

INFANTS WITH VERY HIGH RISK KMT2A B-ALL

Get alerted when new INFANTS WITH VERY HIGH RISK KMT2A B-ALL trials appear

New hope for kids with Ultra-Rare leukemia: re-engineered immune cell trial opens